Head and Neck Cancer
The Challenge
A global biopharmaceutical company wanted to create a policy and advocacy launch strategy for a novel treatment in development for head and neck squamous cell carcinomas (HNSCC) – a new indication for this team.
Our Solution
Analyzed government and payer policies, funding and resourcing priorities, gaps, and proposed legislation.
Mapped patient experience to understand unmet needs:
Insufficient curative treatments
Poor outcomes due to underdiagnosis and late diagnosis
Increased risk of depression and suicidality among stigmatized survivors
Disparities in access to care and socioeconomic status
Chartered the advocacy landscape recommending organizations and KOLs.
Identified shared interests and engagement opportunities aligned to strategic imperatives and launch timelines.
Reviewed competitor activities to identify program strengths and gaps.
Developed a strategic plan to guide policy and patient advocacy engagement activities.
Drafted an operational plan to support smooth execution.
Benefit to Client
Comprehensive HNSCC Policy and Advocacy Insights: Attained insights into the current and evolving HNSCC policy and advocacy landscape.
Influential Stakeholder Comprehension: Understanding of key stakeholders influencing the HNSCC space, unmet patient needs they are working to address, and partnership opportunities to leverage.
Strategic Engagement Blueprint: Developed a policy and advocacy engagement strategy supporting product launch needs.
Policy Monitoring and Stakeholder Engagement: Established a well-defined plan for monitoring pertinent policies in the HNSCC arena and engaging with relevant stakeholders.
